• Home
  • News
  • Portfolio News
  • Platelet BioGenesis Augments Board of Directors with Oncology and Immunotherapy Industry Leader Richard Murray, Ph.D.

Platelet BioGenesis Augments Board of Directors with Oncology and Immunotherapy Industry Leader Richard Murray, Ph.D.

05Jun

Platelet BioGenesis Augments Board of Directors with Oncology and Immunotherapy Industry Leader Richard Murray, Ph.D.

Portfolio News
Platelet BioGenesis, the leader in stem cell-derived, on-demand human platelets (PLTs+™) and platelet-based therapeutics, announced today the addition of Dr. Richard Murray, president and CEO of Jounce Therapeutics, to its board of directors. Read more >>

Share this post

Related Posts

20Dec

LaunchPad Medical Accelerates Enrollment in its First-In-Man Clinical Study

LaunchPad Medical, Inc. announced that it has successfully enrolled half of the twenty patents approved by the FDA for its... read more
01Mar

NextShift Robotics New Space

NextShift Robotics on the ribbon cutting for their new space in Lowell. View on Instagram >> read more
24Jul

Platelet BioGenesis Signs Lease for New Headquarters in Watertown, Mass.

Platelet BioGenesis, Inc. (PBG), the leader in stem cell-derived, on-demand human platelets (PLTs+™) and platelet-based therapeutics, today announced that it... read more
10Nov

eSight Opens First US Office, Bringing New Possibilities to People Living With Visual Impairments

Leading vision enhancement company, eSight, is expanding its global presence with the opening of its first office in the U.S.... read more
10May

Platelet BioGenesis Licenses Induced Pluripotent Stem Cell Technology from iPS Academia Japan

Platelet BioGenesis, a pioneer in the production of functional human platelets (PLTs+™) from stem cells, announced it has licensed patents... read more
10Oct

Marketing enters its digital renaissance

A major movement as part of the Renaissance era, Humanism is defined by scholars as an intellectual movement in which... read more
02Nov

Akston Biosciences Announces Positive Interim Phase II Results from COVID “Universal” Booster Vaccine Trial

Akston Biosciences Corporation, a developer of new classes of biologic therapeutics, today announced top-line clinical results for its Phase II... read more
01Jul

Corbus Pharmaceuticals Expands Pipeline with Two New mAbs

Corbus Pharmaceuticals has licensed two integrin-targeting mAbs, expanding its therapeutics pipeline into inflammatory, fibrotic, and metabolic diseases as well as... read more
12Dec

Born blind, this Columbia student sees a brighter future thanks to visionary glasses Read more here: https://www.thestate.com/news/local/article222567185.html#storylink=cpy

The first time Tori Diamond saw the features of her mother’s face, she saw tears. Read more... read more
04Feb

Shiva Kashalkar Combines Passion and Business in Her “Green Piñata Toys” Venture

Shiva Kashalkar, founder of Green Piñata Toys, is a firm believer that toys should match the rapid mental development of... read more